Cart
sales@molnova.com
SCR-1481B1
CAS No. 1174161-86-4
SCR-1481B1( c-Met inhibitor 2 )
Catalog No. M20163 CAS No. 1174161-86-4
SCR-1481B1 has activity against cancers dependent on Met activation and also has activity against cancers as a VEGFR inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 104 | In Stock |
|
| 2MG | 43 | In Stock |
|
| 5MG | 68 | In Stock |
|
| 10MG | 116 | In Stock |
|
| 25MG | 211 | In Stock |
|
| 50MG | 343 | In Stock |
|
| 100MG | 511 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSCR-1481B1
-
NoteResearch use only, not for human use.
-
Brief DescriptionSCR-1481B1 has activity against cancers dependent on Met activation and also has activity against cancers as a VEGFR inhibitor.
-
DescriptionSCR-1481B1 has activity against cancers dependent on Met activation and also has activity against cancers as a VEGFR inhibitor.(In Vitro):More details please refer to Patent WO 2009094417 A1.
-
In Vitro——
-
In Vivo——
-
Synonymsc-Met inhibitor 2
-
PathwayAngiogenesis
-
TargetVEGFR
-
RecptorVEGFR1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1174161-86-4
-
Formula Weight742.07
-
Molecular FormulaC31H35ClF2N5O10P?
-
Purity>98% (HPLC)
-
SolubilityDMSO:31 mg/mL?(44.29 mM)
-
SMILESNC(CO)(CO)CO.NC(CO)(CO)CO.Nc1nccc(Oc2ccc(NC(=O)c3cn(COP(O)(O)=O)cc(-c4ccc(F)cc4)c3=O)cc2F)c1Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Robert M. Borzilleri et al. 4-pyridinone compounds and their use for cancer. WO/2009094417/A1.
molnova catalog
related products
-
UNC0064-12
2,4-Pyrimidinediamine with linker is a patent compound in WO2013055780A1.
-
Pazopanib hydrochlor...
A potent, orally available, pan-VEGFR inhibitor with IC50 of 10, 30, and 47 nM for VEGFR-1, -2, and -3, respectively.
-
Acrizanib
Acrizanib (LHA510, LHA-510) is a novel potent, selective VEGFR-2 (KDR) inhibitor with IC50 of 17.4 nM in cell-based assays.
